Can mucosal adjuvants contribute to the induction of immunological memory induced via unconjugated T-cell-independent antigens?

References

• Ahlers JD, Belyakov IM. (2010). Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood, 115, 1678–1689.
   PubMed Web of Science ®Google Scholar
• Aiba Y, Kometani K, Hamadate M, Moriyama S, Sakaue-Sawano A, Tomura M, Luche H, Fehling HJ, Casellas R, Kanagawa O, Miyawaki A, Kurosaki T. (2010). Preferential localization of IgG memory B cells adjacent to contracted germinal centers. Proc Natl Acad Sci USA, 107, 12192–12197.
   PubMed Web of Science ®Google Scholar
• Anderson SM, Tomayko MM, Ahuja A, Haberman AM, Shlomchik MJ. (2007). New markers for murine memory B cells that define mutated and unmutated subsets. J Exp Med, 204, 2103–2114.
   PubMed Web of Science ®Google Scholar
• Baudner BC, Balland O, Giuliani MM, Von Hoegen P, Rappuoli R, Betbeder D et al. (2002). Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles. Infect Immun, 47:85–90.
   Google Scholar
• Baudner BC, Verhoef JC, Giuliani MM, Peppoloni S, Rappuoli R, Del Giudice G, Junginger HE. (2005). Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform. J Drug Target, 13, 489–498.
   PubMed Web of Science ®Google Scholar
• Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM; CAIV-T Comparative Efficacy Study Group. (2007). Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med, 356, 685–696.
   PubMed Web of Science ®Google Scholar
• Bjarnarson SP, Jakobsen H, Del Giudice G, Trannoy E, Siegrist CA, Jonsdottir I. (2005). The advantage of mucosal immunization for polysaccharide-specific memory responses in early life. Eur J Immunol, 35, 1037–1045.
   PubMed Web of Science ®Google Scholar
• Brynjolfsson SF, Bjarnarson SP, Mori E, Del Giudice G, Jonsdottir I. (2008). Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006. Vaccine, 26, 4557–4562.
   PubMed Web of Science ®Google Scholar
• Butler NS, Nolz JC, Harty JT. (2011). Immunologic considerations for generating memory CD8 T cells through vaccination. Cell Microbiol, 13, 925–933.
   Google Scholar
• Campo JD, Zayas C, Romeu B, Acevedo R, González E, Bracho G, Cuello M, Cabrera O, Balboa J, Lastre M. (2009). Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. Methods, 49, 301–308.
   PubMed Web of Science ®Google Scholar
• Castellino F, Galli G, Del Giudice G, Rappuoli R. (2009). Generating memory with vaccination. Eur J Immunol, 39, 2100–2105.
   PubMed Web of Science ®Google Scholar
• Chen W, Patel GB, Yan H, Zhang J. (2010). Recent advances in the development of novel mucosal adjuvants and antigen delivery systems. Hum Vaccin, 6,
   Web of Science ®Google Scholar
• Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV. (2000). CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect Immun, 68, 1450–1456.
   PubMed Web of Science ®Google Scholar
• Cox NJ, Bridges CB. (2007). Inactivated and live attenuated influenza vaccines in young children – how do they compare? N Engl J Med, 356, 729–731.
   PubMed Web of Science ®Google Scholar
• da Hora VP, Conceição FR, Dellagostin OA, Doolan DL. (2011). Non-toxic derivatives of LT as potent adjuvants. Vaccine, 29, 1538–1544.
   PubMed Web of Science ®Google Scholar
• Dagan R, Eskola J, Leclerc C, Leroy O. (1998). Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun, 66, 2093–2098.
   PubMed Web of Science ®Google Scholar
• Dagan R, Fraser D. (2000). Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity. Pediatr Infect Dis J, 19, S79–87; discussion S88.
   PubMed Web of Science ®Google Scholar
• Del Campo J, Lindqvist M, Cuello M, Bäckström M, Cabrerra O, Persson J, Perez O, Harandi AM. (2010). Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice. Vaccine, 28, 1193–1200.
   PubMed Web of Science ®Google Scholar
• Duthie MS, Windish HP, Fox CB, Reed SG. (2011). Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev, 239, 178–196.
   PubMed Web of Science ®Google Scholar
• Flanagan MP, Michael JG. (1999). Oral immunization with a Streptococcal pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharides. Vaccine, 17, 72–81.
   PubMed Web of Science ®Google Scholar
• González E, Romeu B, del Campo J, Acevedo R, Lastre M, Zayas C et al. (2009). Mucosal and systemic immune response against Neisseria meningitidis B induced by single time vaccination strategy. VacciMonitor, 18:73–75.
   Google Scholar
• González-Fernández A, Faro J, Fernández C. (2008). Immune responses to polysaccharides: lessons from humans and mice. Vaccine, 26, 292–300.
   PubMed Web of Science ®Google Scholar
• Gourley TS, Wherry EJ, Masopust D, Ahmed R. (2004). Generation and maintenance of immunological memory. Semin Immunol, 16, 323–333.
   Google Scholar
• Harandi AM, Medaglini D. (2010). Mucosal adjuvants. Curr HIV Res, 8, 330–335.
   PubMed Web of Science ®Google Scholar
• Hilleman MR. (2000). Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine, 18, 1436–1447.
   PubMed Web of Science ®Google Scholar
• Jabbal-Gill I. (2010). Nasal vaccine innovation. J Drug Target, 18, 771–786.
   PubMed Web of Science ®Google Scholar
• Jakobsen H, Bjarnarson S, Del Giudice G, Moreau M, Siegrist CA, Jonsdottir I. (2002). Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice. Infect Immun, 70, 1443–1452.
   PubMed Web of Science ®Google Scholar
• Jakobsen H, Jonsdottir I. (2003). Mucosal vaccination against encapsulated respiratory bacteria–new potentials for conjugate vaccines? Scand J Immunol, 58, 119–128.
   PubMed Web of Science ®Google Scholar
• Klinman DM, Klaschik S, Sato T, Tross D. (2009). CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Adv Drug Deliv Rev, 61, 248–255.
   PubMed Web of Science ®Google Scholar
• Lambert PH, Liu M, Siegrist CA. (2005). Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med, 11, S54–S62.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Lee LH, Gu XX. (2005). Mucosal immunity induced by pneumococcal glycoconjugate. Crit Rev Microbiol, 31, 137–144.
   PubMed Web of Science ®Google Scholar
• Lycke N. (2010). Is the choice of vaccine adjuvant critical for long-term memory development? Expert Rev Vaccines, 9, 1357–1361.
   PubMed Web of Science ®Google Scholar
• Lynch JM, Briles DE, Metzger DW. (2003). Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. Infect Immun, 71, 4780–4788.
   PubMed Web of Science ®Google Scholar
• Mann JF, Acevedo R, Campo JD, Pérez O, Ferro VA. (2009). Delivery systems: a vaccine strategy for overcoming mucosal tolerance? Expert Rev Vaccines, 8, 103–112.
   PubMed Web of Science ®Google Scholar
• Mbow ML, De Gregorio E, Valiante NM, Rappuoli R. (2010). New adjuvants for human vaccines. Curr Opin Immunol, 22, 411–416.
   PubMed Web of Science ®Google Scholar
• McHeyzer-Williams MG, Ahmed R. (1999). B cell memory and the long-lived plasma cell. Curr Opin Immunol, 11, 172–179.
   PubMed Web of Science ®Google Scholar
• Morley SL, Cole MJ, Ison CA, Camaraza MA, Sotolongo F, Anwar N, Cuevas I, Carbonero M, Campa HC, Sierra G, Levin M. (2001). Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants. Pediatr Infect Dis J, 20, 1054–1061.
   PubMed Web of Science ®Google Scholar
• Neutra MR, Kozlowski PA. (2006). Mucosal vaccines: the promise and the challenge. Nat Rev Immunol, 6, 148–158.
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Valiante NM. (2003). Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov, 2, 727–735.
   PubMed Web of Science ®Google Scholar
• Patel GB, Zhou H, Ponce A, Chen W. (2007). Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines. Vaccine, 25, 8622–8636.
   PubMed Web of Science ®Google Scholar
• Pérez O, Bracho G, Lastre M, Mora N, del Campo J, Gil D, Zayas C, Acevedo R, y D, López JA, Taboada C, Turtle C, Solis RL. (2004). Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern. Immunol Cell Biol, 82, 603–610.
   PubMed Web of Science ®Google Scholar
• Pérez O, Gonzalez E, Romeu B, Del Campo J, Acevedo R, Lastre M et al. (2008).Single Time Vaccines. Applied Patent OCPI, CU/P/2008/215.
   Google Scholar
• Pérez O, Lastre M, Bracho G, del Campo J, Zayas C, Acevedo R et al. (2006). Natural Neissera derive proteoliposome and cochleate as potent vaccine adjuvant. Pharmacologyonline, 3:762–764.
   Google Scholar
• Pérez O, Lastre M, Cabrera O, del Campo J, Bracho G, Cuello M, Balboa J, Acevedo R, Zayas C, Gil D, Mora N, González D, Pérez R, González E, Barberá R, Fajardo EM, Sierra G, Solís RL, Campa C. (2007). New vaccines require potent adjuvants like AFPL1 and AFCo1. Scand J Immunol, 66, 271–277.
   PubMed Web of Science ®Google Scholar
• Pérez O, Lastre M, Lapinet J, Bracho G, Díaz M, Zayas C, Taboada C, Sierra G. (2001). Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine. Infect Immun, 69, 4502–4508.
   PubMed Web of Science ®Google Scholar
• Pérez O, Romeu B, Lastre M, Gonzalez E, Balboa J, Zayas C et al. (2011). Potent adjuvants to polysaccharides vaccines. CU-P-2011-2002.
   Google Scholar
• Poland GA. (2010). Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Clin Infect Dis, 50 Suppl 2, S45–S53.
   PubMed Web of Science ®Google Scholar
• Rodríguez T, Pérez O, Ménager N, Ugrinovic S, Bracho G, Mastroeni P. (2005). Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery. Vaccine, 23, 1312–1321.
   PubMed Web of Science ®Google Scholar
• Romeu B, González E, Del Campo J, Acevedo R, Zayas C, Valdés Y, Cabrera O, Cuello M, Balboa J, Lastre M, Pérez O. (2011). Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1. Can J Microbiol, 57, 256–261.
   PubMed Web of Science ®Google Scholar
• Romeu B, González E, Zayas C, Del Campo J, Acevedo R, Cuello M, Valdes Y, Balboa J, Cabrera O, Lastre M, Pérez O. (2011). AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses. Scand J Infect Dis, 43, 809–813.
   PubMed Web of Science ®Google Scholar
• Sabirov A, Metzger DW. (2006). Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media. Vaccine, 24, 5584–5592.
   PubMed Web of Science ®Google Scholar
• Taillardet M, Haffar G, Mondière P, Asensio MJ, Pléau-Pison T, Burdin N, Defrance T, Genestier L. (2010). Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine. J Infect Dis, 202, 470–479.
   PubMed Web of Science ®Google Scholar
• Takahashi Y. (2007). Memory B cells in systemic and mucosal immune response: implications for successful vaccination. Biosci Biotechnol Biochem, 71, 2358–2366.
   PubMed Web of Science ®Google Scholar
• Tomayko MM, Steinel NC, Anderson SM, Shlomchik MJ. (2010). Cutting edge: Hierarchy of maturity of murine memory B cell subsets. J Immunol, 185, 7146–7150.
   PubMed Web of Science ®Google Scholar
• Ugozzoli M, Mariani M, Del Giudice G, Soenawan E, O’Hagan DT. (2002). Combinations of protein polysaccharide conjugate vaccines for intranasal immunization. J Infect Dis, 186, 1358–1361.
   PubMed Web of Science ®Google Scholar
• Weintraub A. (2003). Immunology of bacterial polysaccharide antigens. Carbohydr Res, 338, 2539–2547.
   PubMed Web of Science ®Google Scholar
• Williams AE, Edwards L, Humphreys IR, Snelgrove R, Rae A, Rappuoli R, Hussell T. (2004). Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J Immunol, 173, 7435–7443.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Nagumo H, Hayashi T, Sugane K, Agematsu K. (2005). CD72-mediated suppression of human naive B cell differentiation by down-regulating X-box binding protein 1. Eur J Immunol, 35, 2325–2334.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lakshman R, Burkinshaw R, Choo S, Everard J, Akhtar S, Finn A. (2001). Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom. Infect Immun, 69, 4337–4341.
   PubMed Web of Science ®Google Scholar